✦ LIBER ✦

NURR1 in Parkinson disease—from pathogenesis to therapeutic potential

✍ Scribed by Decressac, Mickael; Volakakis, Nikolaos; Björklund, Anders; Perlmann, Thomas

Book ID: 121315371
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 314 KB
Volume: 9
Category: Article
ISSN: 1759-4758
DOI: 10.1038/nrneurol.2013.209

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroinflammation in Alzheimer’s Disease

Neuroinflammation in Alzheimer’s Disease: from Pathogenesis to a Therapeutic Target

✍ Pimplikar, Sanjay W. 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 657 KB

PGC-1 , A Potential Therapeutic Target f

PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease

✍ Zheng, B.; Liao, Z.; Locascio, J. J.; Lesniak, K. A.; Roderick, S. S.; Watt, M. 📂 Article 📅 2010 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 713 KB

Glucocerebrosidase 1 and 2 – Factors to

Glucocerebrosidase 1 and 2 – Factors to Consider in the Pathogenesis of Parkinson's Disease

✍ Derek Burke; Simon Heales 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Angiogenesis in arthritis: role in disea

Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target

✍ Ewa M. Paleolog; Jadwiga M. Miotla 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 144 KB

Cerebral small vessel disease: from path

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

✍ Pantoni, Leonardo (author) 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 1015 KB

Cerebral small vessel disease: from path

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

✍ Pantoni, Leonardo (author) 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 1015 KB